Schilling R F, McKnight B, Crowley J J
J Lab Clin Med. 1982 Mar;99(3):382-7.
The serum LDH level determined at time of diagnosis provides important prognostic information about patients with Hodgkin's disease. The median survival of patients with a normal value was 129 months, whereas those with elevated values had a median survival of only 39 months. The prognostic power of LDH persisted after adjustment for age, symptom class, stage, or histology. When the Cox proportional hazards regression method was used to simultaneously adjust for age, histology, symptom class, and stage, elevated enzyme levels still were correlated with short survival. (J Lab Clin Med 99:382, 1982.)
诊断时测定的血清乳酸脱氢酶(LDH)水平可为霍奇金病患者提供重要的预后信息。LDH值正常的患者中位生存期为129个月,而LDH值升高的患者中位生存期仅为39个月。在对年龄、症状分级、分期或组织学进行校正后,LDH的预后价值依然存在。当使用Cox比例风险回归方法同时对年龄、组织学、症状分级和分期进行校正时,酶水平升高仍与生存期短相关。(《实验室与临床医学杂志》99:382, 1982.)